Status: Not yet recruiting
A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis
The study is being conducted to evaluate the efficacy and safety of Ribupatide Injection in participants with obesity and knee osteoarthritis, and to explore its improvement on knee joint structure.
Participants needed: 382
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Updated: Jul 17, 2026Locations: 1
Eligibility criteria
2、Aged ≥18 years on the date of signing the informed consent form, male or femal... [+3]
Existence of endocrine diseases that may significantly affect body weight; [+15]